Press Release: BB Biotech AG : Disclosure pursuant to article 26 sec 1 clause 2 WpHG (own shares) as at January 20, 2015

BB Biotech AG / BB Biotech AG : Disclosure pursuant to article 26 sec 1 clause 2 WpHG (own shares) as at January 20, 2015 . Processed and transmitted by Nasdaq OMX Corporate Solutions. The issuer is solely responsible for the content of this announcement.

Disclosure of shareholding

Pursuant to article 26 sec 1 clause 2 WpHG, BB Biotech AG, Schaffhausen, Switzerland, herby reports that it increased its holding in own shares to more than 5% of the proportion of voting rights as of January 16, 2015 (a total of 603 708 shares / 5.09% of the proportion of voting rights).

Thereof, 0.34% of the proportion of voting rights (a total of 41 008 shares) are held through its wholly-owned subsidiary Biotech Target N.V., Curaçao.

For further information: Bellevue Asset Management AG, Seestrasse 16, 8700 Küsnacht / Zürich

Tanja Chicherio, Tel. +41 44 267 67 00.

Schaffhausen, January 20, 2015

BB Biotech AG

Release (PDF): http://hugin.info/136834/R/1888030/668037.pdf

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.

The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: BB Biotech AG via Globenewswire

HUG#1888030

--- End of Message ---

BB Biotech AG

Vordergasse 3 Schaffhausen Switzerland

WKN: 888509;ISIN: CH0038389992;Index:TecDAX,MIDCAP,Prime All Share,TECH All Share,HDAX;

Listed: Regulierter Markt in Frankfurter Wertpapierbörse;

http://www.bbbiotech.com (END) Dow Jones Newswires

   January 20, 2015 01:30 ET (06:30 GMT)- - 01 30 AM EST 01-20-15